BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11417989)

  • 1. Incidence and clinical course of de-novo malignancies in renal allograft recipients.
    Winkelhorst JT; Brokelman WJ; Tiggeler RG; Wobbes T
    Eur J Surg Oncol; 2001 Jun; 27(4):409-13. PubMed ID: 11417989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
    Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
    Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of neoplasm occurrence of renal allograft recipients and their prognosis].
    Wang CX; Liu LS; Chen LZ; Wu PG; Xie D; Fei JG; Qiu J; Deng SX; Zheng KL; Ji YL; Zhu LY; Shen QR; He XS
    Ai Zheng; 2005 Feb; 24(2):222-5. PubMed ID: 15694039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
    Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
    Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience.
    Roithmaier S; Haydon AM; Loi S; Esmore D; Griffiths A; Bergin P; Williams TJ; Schwarz MA
    J Heart Lung Transplant; 2007 Aug; 26(8):845-9. PubMed ID: 17692790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo gastrointestinal tumours after renal transplantation: role of CMV and EBV viruses.
    Adani GL; Baccarani U; Lorenzin D; Gropuzzo M; Tulissi P; Montanaro D; Currö G; Sainz M; Risaliti A; Bresadola V; Bresadola F
    Clin Transplant; 2006; 20(4):457-60. PubMed ID: 16842521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo malignances in pediatric organ transplant recipients.
    Penn I
    Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal transplantation and malignancies: A single-centre experience (25 years)].
    Stefoni S; Scolari MP; Sestigiani E; Faenza A; Campieri C; Buscaroli A; Liviano D'Arcangelo G; D'Addio F
    G Ital Nefrol; 2002; 19(6):650-7. PubMed ID: 12508170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urological malignancy after renal transplantation.
    Besarani D; Cranston D
    BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
    Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
    BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.